6533b851fe1ef96bd12aa080
RESEARCH PRODUCT
KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis
A.s. JungKelly S. OlinerScott D. PattersonTimothy J. PriceT. AndreAndrés CervantesC.j.a. PuntEmily ChanHua YuMonika PeetersLaslo RomanFlorian LordickYevhen HotkoA. H. StricklandGregory C. WilsonMichel DucreuxAlberto SobreroTudor-eliade CiuleanuRoger SidhuE. Van Cutsemsubject
OncologyNeuroblastoma RAS viral oncogene homologmedicine.medical_specialtyColorectal cancerbusiness.industryHematologymedicine.diseaseOncologyInternal medicineMutation (genetic algorithm)medicineCancer researchFOLFIRIPanitumumabLine (text file)businessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2014-06-01 | Annals of Oncology |